BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 24999831)

  • 1. Gender difference in association of cognition with BDNF in chronic schizophrenia.
    Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Xiu MH; Hui L; Lv MH; Zunta-Soares GB; Soares JC
    Psychoneuroendocrinology; 2014 Oct; 48():136-46. PubMed ID: 24999831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia.
    Man L; Lv X; Du XD; Yin G; Zhu X; Zhang Y; Soares JC; Yang XN; Chen X; Zhang XY
    Psychiatry Res; 2018 May; 263():1-6. PubMed ID: 29482040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia.
    Niitsu T; Shirayama Y; Matsuzawa D; Hasegawa T; Kanahara N; Hashimoto T; Shiraishi T; Shiina A; Fukami G; Fujisaki M; Watanabe H; Nakazato M; Asano M; Kimura S; Hashimoto K; Iyo M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1836-40. PubMed ID: 21930178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia.
    Zhang XY; Liang J; Chen DC; Xiu MH; Yang FD; Kosten TA; Kosten TR
    Psychopharmacology (Berl); 2012 Jul; 222(2):277-84. PubMed ID: 22274000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia.
    Ichioka S; Terao T; Hoaki N; Matsushita T; Hoaki T
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):170-4. PubMed ID: 22750309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
    Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
    Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interplay between BDNF and oxidative stress in chronic schizophrenia.
    Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Okusaga OO; Zunta-Soares GB; Soares JC
    Psychoneuroendocrinology; 2015 Jan; 51():201-8. PubMed ID: 25462893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BDNF serum levels and cognitive improvement in drug-naive first episode patients with schizophrenia: A prospective 12-week longitudinal study.
    Wu ZW; Shi H; Chen DC; Chen S; Xiu MH; Zhang XY
    Psychoneuroendocrinology; 2020 Dec; 122():104879. PubMed ID: 33049658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia.
    Reis HJ; Nicolato R; Barbosa IG; Teixeira do Prado PH; Romano-Silva MA; Teixeira AL
    Neurosci Lett; 2008 Jul; 439(2):157-9. PubMed ID: 18514407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients.
    Zhang XY; Chen DC; Xiu MH; Yang FD; Haile CN; Kosten TA; Kosten TR
    J Clin Psychiatry; 2012 Jul; 73(7):1025-33. PubMed ID: 22901352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor is associated with cognitive impairments in first-episode and chronic schizophrenia.
    Yang Y; Liu Y; Wang G; Hei G; Wang X; Li R; Li L; Wu R; Zhao J
    Psychiatry Res; 2019 Mar; 273():528-536. PubMed ID: 30710808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
    Xiu MH; Hui L; Dang YF; Hou TD; Zhang CX; Zheng YL; Chen DC; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1508-12. PubMed ID: 19720106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder.
    Dias VV; Brissos S; Frey BN; Andreazza AC; Cardoso C; Kapczinski F
    Bipolar Disord; 2009 Sep; 11(6):663-71. PubMed ID: 19689509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.
    Tan YL; Zhou DF; Cao LY; Zou YZ; Zhang XY
    Neurosci Lett; 2005 Jul 1-8; 382(1-2):27-32. PubMed ID: 15911116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia.
    Asevedo E; Gadelha A; Noto C; Mansur RB; Zugman A; Belangero SI; Berberian AA; Scarpato BS; Leclerc E; Teixeira AL; Gama CS; Bressan RA; Brietzke E
    J Psychiatr Res; 2013 Oct; 47(10):1376-82. PubMed ID: 23806580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) to investigate group and gender differences in schizophrenia and bipolar disorder.
    Gogos A; Joshua N; Rossell SL
    Aust N Z J Psychiatry; 2010 Mar; 44(3):220-9. PubMed ID: 20050718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in cognitive function of patients with chronic schizophrenia.
    Han M; Huang XF; Chen DC; Xiu MH; Hui L; Liu H; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):358-63. PubMed ID: 22820676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BDNF serum concentrations in first psychotic episode drug-naïve schizophrenic patients: associations with personality and BDNF Val66Met polymorphism.
    Sotiropoulou M; Mantas C; Bozidis P; Marselos M; Mavreas V; Hyphantis T; Antoniou K
    Life Sci; 2013 Mar; 92(4-5):305-10. PubMed ID: 23333821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered BDNF is correlated to cognition impairment in schizophrenia patients with tardive dyskinesia.
    Wu JQ; Chen DC; Tan YL; Tan SP; Hui L; Lv MH; Soares JC; Zhang XY
    Psychopharmacology (Berl); 2015 Jan; 232(1):223-32. PubMed ID: 24994553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
    Pirildar S; Gönül AS; Taneli F; Akdeniz F
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.